Wells Fargo Maintains Equal-Weight on Amgen, Lowers Price Target to $430

Benzinga Newsdesk www.benzinga.com Neutral 53.5%

Neg 0% Neu 53.5% Pos 0%

Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $435 to $430.